Equities

EchoIQ Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

EchoIQ Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.51
  • Today's Change0.035 / 7.37%
  • Shares traded3.52m
  • 1 Year change+85.45%
  • Beta0.9657
Data delayed at least 20 minutes, as of Feb 11 2026 05:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

EchoIQ Limited is an Australia-based artificial intelligence (AI) and medical technology company. The Company uses AI-driven technology and software to improve decision-making in cardiology. The principal activity of the Company is the development of AI software that aids in predicting Aortic Stenosis heart condition. The Company’s EchoSolv platform harnesses AI-driven analysis of echocardiographic data to assist clinicians in detecting aortic stenosis and other conditions. Its EchoSolv product allows users to assess echocardiographic studies against diagnostic guidelines for structural heart conditions. EchoSolv automatically identifies patients at risk of structural heart disease. EchoSolv improves the standard clinical workflow associated with diagnosis and treatment. The Company’s subsidiaries include HWH Software Pty Ltd, Echo IQ Global Pty Ltd and Echo IQ Incorporated.

  • Revenue in AUD (TTM)101.41k
  • Net income in AUD-13.26m
  • Incorporated2010
  • Employees--
  • Location
    EchoIQ LtdSuite 404, 309 George StreetSYDNEY 2000AustraliaAUS
  • Phone+61 29159-3719
  • Fax+61 28039-0534
  • Websitehttps://www.echoiq.ai/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
EMvision Medical Devices Ltd5.63m-9.81m167.75m----16.63--29.80-0.1148-0.11480.06590.10860.2847--694.01---49.59-47.15-58.91-58.42-----174.21-105.97---93.340.2758---51.3141.83-259.23------
Lumos Diagnostics Holdings Ltd17.68m-10.24m210.20m----22.60--11.89-0.0149-0.01490.0260.01170.52057.044.91---30.15-40.19-54.60-61.1662.9552.57-57.93-132.460.6816-10.690.5315--11.4017.1216.40---61.58--
Aroa Biosurgery Ltd77.53m-1.56m241.83m261.00--3.05143.073.12-0.0045-0.00450.22470.22960.84321.563.08---1.70-8.53-1.85-9.7585.0782.71-2.01-15.205.740.31420.0706--22.6327.5664.12--14.62--
Orthocell Ltd8.85m-8.57m253.67m----15.62--28.66-0.0375-0.03750.03970.05990.28622.319.20---27.70-28.14-34.17-33.4768.9871.87-96.78-167.824.78--0.0381--36.4161.65-19.30--45.43--
Saluda Medical Inc-100.00bn-100.00bn301.17m--------------------------------------------------36.13---52.62------
EchoIQ Ltd101.41k-13.26m304.01m----13.18--2,997.84-0.0226-0.02260.00020.03530.0064--0.6446---83.87-68.78-89.84-81.95-----13,078.12-3,892.98----0.00--127.89-31.65-145.19---16.56--
Paragon Care Ltd3.62bn20.57m322.78m0.0015.700.97866.400.08920.01240.01242.180.19933.0211.9010.33--1.721.794.474.079.048.900.56880.60810.61551.770.4699--21.7273.23151.52--18.34--
EBR Systems Inc971.91k-63.88m351.03m----6.37--361.18-0.1706-0.17060.00260.12250.0074--0.4935---48.75-60.71-53.75-74.7645.20---6,572.14--7.01-15.000.5131-------16.44--2.46--
Data as of Feb 11 2026. Currency figures normalised to EchoIQ Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

0.27%Per cent of shares held by top holders
HolderShares% Held
BetaShares Capital Ltd.as of 31 Dec 20251.73m0.27%
Data from 05 Feb 2026 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.